Chenodeoxycholic Acid
ATC A05AA01 · 4 markets · 9 records
GB 5 records · 3 strengths
- 250 mgcapsuleXenbilox 250mg capsules__no_trade__
- 250 mgtabletChenodiol
- 200 mgtabletNo trade name
TW 2 records · 1 strengths
- 250 mgcapsule"國嘉" 石立消膠囊250毫克(去諾第氧膽酸)AYLEHNING CAPSULES 250MG "C.M." (CHENODEOXYCHOLIC ACID)、CHENO CAPSULES 250MG "KOJAR" (CHENODEOXYCHOLIC ACID)、愛樂寧膠囊２５０公絲（去諾第氧膽酸）
HK 1 records · 1 strengths
Records without a stated strength · 1 SULISOU CAP 250MG (KOJAR)
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Chenodeoxycholic acid Leadiant
| Strength / form / release | GB | TW | HK | EU |
|---|---|---|---|---|
| 250 mg capsule | No trade name Xenbilox 250mg capsules | "國嘉" 石立消膠囊250毫克(去諾第氧膽酸) AYLEHNING CAPSULES 250MG "C.M." (CHENODEOXYCHOLIC ACID) CHENO CAPSULES 250MG "KOJAR" (CHENODEOXYCHOLIC ACID) | ||
| 250 mg tablet | Chenodiol | |||
| 200 mg tablet | No trade name | |||
unknown | SULISOU CAP 250MG (KOJAR) | Chenodeoxycholic acid Leadiant |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.